The group’s principal activity is to provide automation of research and the genomics revolution in the drug discovery and development process. The group also provides systems for managing of data. The group provides solutions that enable pharmaceutical and biotechnology companies to capture, integrate, manage and analyze life-sciences and clinical trial data. The group operates from United States.
